Basit öğe kaydını göster

Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study

dc.contributor.authorYilmaz, Deniz Demir
dc.contributor.authorMusellim, Benan
dc.contributor.authorBÖREKÇİ, Şermin
dc.date.accessioned2021-12-10T12:49:58Z
dc.date.available2021-12-10T12:49:58Z
dc.identifier.citationYilmaz D. D. , BÖREKÇİ Ş., Musellim B., "Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study", CLINICAL RHEUMATOLOGY, cilt.40, ss.4071-4079, 2021
dc.identifier.issn0770-3198
dc.identifier.othervv_1032021
dc.identifier.otherav_dae75552-7266-4d6d-93b7-810dfe2ea373
dc.identifier.urihttp://hdl.handle.net/20.500.12627/174791
dc.identifier.urihttps://doi.org/10.1007/s10067-021-05785-6
dc.description.abstractObjectives To compare the effectiveness of cyclophosphamide and rituximab in the treatment of patients with systemic sclerosis with pulmonary involvement (SSc-ILD).
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectRheumatology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleComparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study
dc.typeMakale
dc.relation.journalCLINICAL RHEUMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , ,
dc.identifier.volume40
dc.identifier.startpage4071
dc.identifier.endpage4079
dc.contributor.firstauthorID2638063


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster